LYTIR

Insider · SEC Form 4 · President, Oncology

Roberto Wandenkolk Vieira

Filed with the SEC as Vieira Roberto Wandenkolk; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $8.1M of CORT. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $8.1M in total.Sep: Insider sales $6.5MOct: Insider sales $967KNov: Insider sales $674KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $8.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. CORTSold: CORCEPT THERAPEUTICS INC Nov 2, 2026 8,333 shares filed Nov 4, 2026 2 transactions 10b5-1 plan filing $674K
  2. CORTSold: CORCEPT THERAPEUTICS INC Oct 2, 2026 8,333 shares filed Oct 5, 2026 3 transactions 10b5-1 plan filing $967K
  3. CORTSold: CORCEPT THERAPEUTICS INC Sep 16, 2026 296 shares filed Sep 18, 2026 3,946 shares held directly after, as filed 10b5-1 plan filing $30K
  4. CORTSold: CORCEPT THERAPEUTICS INC Sep 2, 2026 58,333 shares filed Sep 3, 2026 7 transactions 10b5-1 plan filing $6.5M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • CORT: option exercise or conversion (code M), 3 entries, Sep 2 to Nov 2, 2026
  • CORT: grant or award (code A), 2 entries, Sep 1, 2026
  • CORT: shares withheld for tax or exercise price (code F), 1 entry, Sep 2, 2026
Code A
A grant or award from the company, such as stock given as pay.
Code F
Shares paid to, or withheld by, the company to cover an exercise price or the tax due on an award.
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.